Johson &Johnson

Boost for prostrate cancer patients as NHIF covers access to key drug

The National Health and Insurance Funds (NHIF) has added Zytiga (Abiraterone), a prostrate cancer drug that costs approximately Sh100,000 to the scheme. This...

Brenda Gamonde